In vitro sensitivity of human ovarian tumors to chemotherapeutic agents with adjuvant danazol

Obstetrics & Gynecology · 1987 · vol. 69(2) , pp. 233–6 · PMID:3808508 · W3012618233
Lab / animal OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-05 ⓘ

This study determined the in vitro chemosensitivity of human ovarian tumors to various agents alone and with danazol, observing a uniform increase in sensitivity when danazol was present.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Human ovarian tumors have been cultured as primary monolayers in vitro. The in vitro chemosensitivity was determined indirectly using [3H]leucine uptake with cisplatinum, adriamycin, bleomycin, thiotepa, and chlorambucil. Chemosensitivity also was determined using these agents in the presence of danazol. The tumor cultures showed a uniform increase in sensitivity to these agents in the presence of danazol, suggesting that this drug might merit testing as an adjuvant in the chemotherapy of ovarian cancer.

My notes (saved in your browser only)

MeSH descriptors

Antineoplastic Combined Chemotherapy Protocols Danazol Ovarian Neoplasms Pregnadienes Antineoplastic Combined Chemotherapy Protocols Danazol Female Humans In Vitro Techniques Leucine Leucine Ovarian Neoplasms Ovarian Neoplasms Ovarian Neoplasms Pregnadienes Protein Biosynthesis Tumor Stem Cell Assay

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T10:28:58.613024+00:00
pubmed
last seen: 2026-10-08T21:42:09.747210+00:00
License: CC0 · commercial use OK